4//SEC Filing
REVA Medical, Inc. 4
Accession 0001209191-16-129781
CIK 0001496268operating
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 7:31 PM ET
Size
11.8 KB
Accession
0001209191-16-129781
Insider Transaction Report
Form 4
REVA Medical, Inc.RVA:AX
Brandom Donald K.
VP, Biomaterials Product Dev
Transactions
- Sale
Common Stock
2016-06-23$7.79/sh−463$3,609→ 74,587 total - Sale
Common Stock
2016-06-24$7.44/sh−5.4$40→ 74,118.6 total - Sale
Common Stock
2016-06-23$7.79/sh−463$3,609→ 74,124 total - Sale
Common Stock
2016-06-24$7.36/sh−1,000$7,365→ 73,118.6 total - Sale
Common Stock
2016-06-24$7.29/sh−2,074$15,119→ 71,044.6 total
Footnotes (5)
- [F1]Represents the sale of 4,630 of the Company's Chess Depository Interests (CDIs) trading on the Australian Securities Exchange ("ASX").
- [F2]The sale was executed in the form of CDIs trading on the ASX and, as such, the sale price has been converted to a USD equivalent, adjusting for the conversion ratio of 1 share of common stock per 10 CDIs, and the exchange rate on the date of the transaction.
- [F3]Represents the sale of 54 of the Company's CDIs trading on the ASX.
- [F4]Represents the sale of 10,000 of the Company's CDIs trading on the ASX.
- [F5]Represents the sale of 20,740 of the Company's CDIs trading on the ASX.
Documents
Issuer
REVA Medical, Inc.
CIK 0001496268
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001496268
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 7:31 PM ET
- Size
- 11.8 KB